Telo Genomics and Emery Pharma Announce Collaboration to Enhance Oncology Testing
This partnership aims to offer complementary cellular and molecular bioanalytical solutions for clinical research and development initiatives to their respective clients.
Oncology Testing | 18/05/2024 | By Abha | 212
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy